Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Wegovy has been MHRA-approved since September 2021 (2.4 mg) and January 2026 (7.2 mg), NICE-recommended since March 2023, and has a positive cardiovascular outcomes trial behind it
Reconstituted solution is characteristically blue (copper salt in solution, not contamination).
No pharmaceutical company has funded the human clinical trials required for FDA approval
Our team will monitor you closely and provide guidance to manage any side effects
US$ 29.54
US$ 26.51
US$ 27.71
US$ 26.53
US$ 24.40
US$ 25.85
